Live Breaking News & Updates on Genetics Trading Down

Stay updated with breaking news from Genetics trading down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Myriad Genetics (NASDAQ:MYGN) Posts Quarterly Earnings Results, Beats Estimates By $0.09 EPS

Myriad Genetics (NASDAQ:MYGN) Posts Quarterly Earnings Results, Beats Estimates By $0.09 EPS
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United States , Goldman Sachs Group , Genetics Inc , Myriad Genetics , Get Free Report , Genetics Trading Down , Myrisk Hereditary Cancer Test , Germline Companion Diagnostic Test , Companion Diagnostic Test , Myriad Genetics Daily ,

Myriad Genetics, Inc. (NASDAQ:MYGN) Given Consensus Rating of "Hold" by Brokerages

Myriad Genetics, Inc. (NASDAQ:MYGN) Given Consensus Rating of "Hold" by Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , New Zealand General , New Zealand , Genetics Inc , Wellington Management Group , Virtu Financial , Vanguard Group Inc , Fisher Asset Management , Allspring Global Investments Holdings , Goldman Sachs Group , Myriad Genetics , Get Free Report , Genetics Trading Down , Global Investments Holdings , Asset Management , Management Group , Get Free , Myrisk Hereditary Cancer Test , Germline Companion Diagnostic Test , Companion Diagnostic Test , Myriad Genetics Daily ,

Brokerages Set Myriad Genetics, Inc. (NASDAQ:MYGN) Price Target at $23.17

Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have been given an average rating of “Hold” by the six brokerages that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to […] ....

Hong Kong , United States , Tower Research Capital , Goldman Sachs Group , Genetics Company Profile , Hong Kong Ltd , Royal Bank , China Universal Asset Management Co , Genetics Inc , Myriad Genetics , Get Free Report , Genetics Trading Down , Universal Asset Management , Kong Ltd , Research Capital , Get Free , Myrisk Hereditary Cancer Test , Germline Companion Diagnostic Test , Companion Diagnostic Test , Myriad Genetics Daily , Nasdaq Mygn ,

Myriad Genetics (NASDAQ:MYGN) Updates FY24 Earnings Guidance

Myriad Genetics (NASDAQ:MYGN) Updates FY24 Earnings Guidance
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Piper Sandler , Wells Fargo Company , Vanguard Group Inc , Group Plc , Wolfe Research , Goldman Sachs Group , Pricet Rowe Associates Inc , Genetics Inc , Barclays Plc , Genetics Company Profile , Voloridge Investment Management , Myriad Genetics , Get Free Report , Genetics Trading Down , General Group Plc , Myrisk Hereditary Cancer Test , Germline Companion Diagnostic Test , Companion Diagnostic Test , Myriad Genetics Daily ,

Fulgent Genetics (NASDAQ:FLGT) Updates FY 2024 Earnings Guidance

Fulgent Genetics (NASDAQ:FLGT – Get Free Report) updated its FY 2024 earnings guidance on Wednesday. The company provided EPS guidance of -1.050–1.050 for the period, compared to the consensus EPS estimate of -0.950. The company issued revenue guidance of $280.0 million-$280.0 million, compared to the consensus revenue estimate of $294.2 million. Fulgent Genetics also updated […] ....

United States , Jian Xie , Paul Kim , Nuveen Asset Management , Fulgent Genetics Inc , Pricet Rowe Associates Inc , Barclays Plc , Vanguard Group Inc , Securities Exchange Commission , Fulgent Genetics , Get Free Report , Genetics Trading Down , Exchange Commission , Asset Management , Occudo Quantitative Strategies , Fulgent Genetics Daily ,